Article (Scientific journals)
2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint.
Zhang, Zhiyi; Huang, Cibo; Cao, Yongping et al.
2021In Aging Clinical and Experimental Research, 33 (8), p. 2141-2147
Peer Reviewed verified by ORBi
 

Files


Full Text
s40520-021-01906-y.pdf
Publisher postprint (471.55 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Algorithm; China; Knee osteoartrhitis; Patented crystalline glucosamine sulfate; Symptomatic slow-acting drugs for osteoarthritis
Abstract :
[en] AIM: The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) algorithm for the management of knee osteoarthritis (OA) is available worldwide from 2014, but in 2019 an update was published. Based on this algorithm, a Working Group (WG), including ESCEO members and Chinese experts, wished to see how the new ESCEO algorithm was perceived by Chinese experts in knee OA and how it was integrated into their clinical practice. METHODS: A WG was held between members of the international ESCEO task force and a group of Chinese experts. RESULTS: Non-pharmacological approach should be combined with pharmacological interventions. In step 1, symptomatic slow-acting drugs for osteoarthritis (SYSADOA) are the most important background drugs. Evidence, supported by high-quality research, is available only for crystalline glucosamine sulfate (pCGS) and chondroitin sulfate. Topical NSAIDs could be used as an additional option. In step 2, oral NSAIDs could be useful, but cardiovascular/renal/gastrointestinal profiles of the patients should be considered. Intra-articular hyaluronic acid and corticosteroids are alternative to oral NSAIDs, but the evidence is still limited. If steps 1 and 2 are not sufficient, weak opioids could be used. Overall, the conclusions of the ESCEO algorithm are accepted in China for products available in this country. The WG suggests the importance of economic studies, specifically made in China. CONCLUSION: This work provides evidence-based advice to establish a treatment algorithm in knee OA, for practical implementation in clinical practice in China.
Disciplines :
Public health, health care sciences & services
Laboratory medicine & medical technology
Author, co-author :
Zhang, Zhiyi
Huang, Cibo
Cao, Yongping
Mu, Rong
Zhang, Mun Chan
Xing, Dan
Fan, Dongwei
Ding, Yunpong
Guo, Junhuan
Hou, Yong
Jianhao, Lin
Veronese, Nicola
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Cavalier, Etienne  ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Zhang, Huaihuan
More authors (6 more) Less
Language :
English
Title :
2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint.
Publication date :
2021
Journal title :
Aging Clinical and Experimental Research
ISSN :
1594-0667
eISSN :
1720-8319
Publisher :
Springer, Germany
Volume :
33
Issue :
8
Pages :
2141-2147
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 26 July 2021

Statistics


Number of views
75 (5 by ULiège)
Number of downloads
29 (4 by ULiège)

Scopus citations®
 
13
Scopus citations®
without self-citations
8
OpenCitations
 
9

Bibliography


Similar publications



Contact ORBi